(S (NP-SBJ-COOD-3 (NP (NP (NN Activation)) (PP (IN of) (NP (NN protein) (NN kinase) (NN C)))) (CC and) (NP (NP (NN elevation)) (PP (IN of) (NP (NN cAMP))))) (VP (VBP interact) (ADVP (RB synergistically)) (S (NP-SBJ (-NONE- *-3)) (VP (TO to) (VP (VB raise) (NP (NP (NP-COOD (NP (NN c-Fos)) (CC and) (NP (NN AP-1))) (NN activity)) (PP (IN in) (NP (NN Jurkat) (NNS cells)))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (ADVP-TMP (RBR earlier)) (VP (VBN found) (SBAR (IN that) (S (PP (IN in) (NP (NN Jurkat) (NNS cells))) (NP-SBJ (NP (NN activation)) (PP (IN of) (NP (NP (NN protein) (NN kinase) (NN C)) (PRN (-LRB- -LRB-) (NP (NN PKC)) (-RRB- -RRB-))))) (VP (VBZ enhances) (NP (NP (DT the) (NP (NP (JJ cyclic) (NN adenosine) (NN monophosphate)) (PRN (-LRB- -LRB-) (NP (NN cAMP)) (-RRB- -RRB-))) (NN accumulation)) (VP (VBN induced) (NP (-NONE- *)) (PP (IN by) (NP-LGS-COOD (NP (NN adenosine) (NN receptor) (NN stimulation)) (CC or) (NP (NP (NN activation)) (PP (IN of) (NP (NN Gs))))))))))))) (. .))
(S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP have) (ADVP (RB therefore)) (VP (VBN examined) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (DT the) (NN phorbol) (NN ester) (NP (NP (NN PMA)) (PRN (-LRB- -LRB-) (NP (NN phorbol) (NN 12-myristate) (NN 13-acetate)) (-RRB- -RRB-)))) (SBAR (WHNP-4 (WDT which)) (S (NP-SBJ (-NONE- *T*-4)) (VP (VBZ stimulates) (S (NP-SBJ-COOD (NP (NN PKC)) (CC and) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP-COOD (NP (DT the) (NN adenosine) (NN receptor) (NN agonist) (NP (NP (NN NECA)) (PRN (-LRB- -LRB-) (NP (JJ 5'--LRB-N-ethyl-RRB--carboxamido) (NN adenosine)) (-RRB- -RRB-)))) (CC and) (NP (NN forskolin)))))) (VP (TO to) (VP (VB raise) (NP (NN cAMP)))))))))) (, ,) (PP-COOD (PP (IN on) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP-COOD (NP (NN c-Fos)) (CC and) (NP (NN Jun)))))) (CC and) (PP (IN on) (NP (NP (DT the) (NP-COOD (NP (VBG binding)) (CC and) (NP (JJ transcriptional) (NN activity)))) (PP (IN of) (NP (NP (DT the) (NN transcription) (NN factor)) (, ,) (NP (NP (NN activator) (NN protein-1)) (PRN (-LRB- -LRB-) (NP (NN AP-1)) (-RRB- -RRB-))))))))))) (. .))
(S (NP-SBJ (NN PMA) (NN treatment)) (VP (VBD caused) (NP (NP (DT a) (ADJP-COOD (ADJP (NP (NN concentration-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (JJ time-dependent))) (NN increase)) (PP (IN in) (NP (NP-COOD (CC both) (NP (NN c-Fos)) (CC and) (NP (NN Jun))) (NN immunoreactivity)))) (PP (IN in) (NN contrast) (TO to) (NP (NP (NN cAMP) (NN elevation)) (SBAR (WHNP-5 (WDT that)) (S (NP-SBJ (-NONE- *T*-5)) (VP (VBD had) (NP (RB only) (DT a) (JJ slight) (NN effect)))))))) (. .))
(S (NP-SBJ-COOD-6 (CC Both) (NP (NN PMA)) (CC and) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP-COOD (NP (NN NECA)) (CC and) (NP (NN forskolin)))))) (VP (VBD acted) (ADVP (RB together)) (S (NP-SBJ-7 (-NONE- *-6)) (VP (CC either) (VP (TO to) (VP (VP-COOD (VP (VB increase) (NP (-LRB- -LRB-) (NP (NN c-Fos)) (-RRB- -RRB-) (NP (-NONE- *RNR*-8)))) (CC or) (VP (VB decrease) (NP (-LRB- -LRB-) (NP (NN Jun)) (-RRB- -RRB-) (NP (-NONE- *RNR*-8))))) (NP-8 (NN protein) (NNS levels)) (PP (RB as) (RB well) (IN as) (S (NP-SBJ (-NONE- *-7)) (VP (VP (VBG increasing) (NP-101 (NN AP-1) (NN binding)) (, ,) (SBAR (IN as) (S (NP-SBJ-9 (-NONE- *)) (VP (VBN judged) (NP (-NONE- *-9)) (PP (IN by) (NP-LGS (NN gel-shift) (NN assay)))))) (, ,)) (CC and) (VP (NP=101 (NN AP-1) (JJ transcriptional) (NN activity))))))))))) (. .))
(S (ADVP (RB Furthermore)) (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (DT a) (JJ clear-cut) (NN synergy)) (PP (IN between) (NP-COOD (NP (DT the) (NN PKC) (NN stimulator)) (CC and) (NP (DT the) (NN cAMP) (NN elevating) (NNS agents))))) (. .))
(S (NP-SBJ (DT The) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (DT the) (JJ simultaneous) (NP-COOD (NP (NP (NN activation)) (PP (IN of) (NP (NN PKC)))) (CC and) (NP (NP (NN elevation)) (PP (IN of) (NP (NN cAMP)))))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT an) (VBN enhanced) (NN AP-1) (JJ transcriptional) (NN activity)) (PP (IN in) (NP (DT a) (NN T-leukemia) (NN cell) (NN line))))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (ADJP (RB previously) (VBN observed)) (NN interaction)) (PP (IN between) (NP (DT the) (JJ parallel) (NN signal) (NN transduction) (NNS pathways)))) (VP (MD may) (VP (VB have) (NP (JJ functional) (NNS consequences)) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN gene) (NN transcription))))))))))))))) (. .))
